Tumor oxygenation and acidification are increased in melanoma xenografts after exposure to hyperglycemia and meta-iodo-benzylguanidine

Radiation Research

Volumn 159, Issue 3, 2003, Pages 328-335

  Burd, Randy ^a   Lavorgna, Stephanie N ^a   Daskalakis, Constantine ^b   Wachsberger, Phyllis R ^a   Wahl, Miriam L ^c   Biaglow, John E ^d   Stevens, Craig W ^e   Leeper, Dennis B ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE; GLUCOSE; HYPERGLYCEMIC AGENT;

ACIDIFICATION; ACIDITY; ANIMAL EXPERIMENT; ARTICLE; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CANCER THERAPY; CELL PH; CONTROLLED STUDY; EXPOSURE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; HYPERGLYCEMIA; MELANOMA; MOUSE; NONHUMAN; OXYGEN CONSUMPTION; OXYGEN TENSION; PRIORITY JOURNAL; SCID MOUSE; TISSUE OXYGENATION; XENOGRAFT;

ANIMALS; BLOOD GLUCOSE; GLUCOSE; GUANIDINES; HUMANS; HYDROGEN-ION CONCENTRATION; HYPERGLYCEMIA; MELANOMA; MICE; MICE, SCID; NEOPLASM TRANSPLANTATION; NEOPLASMS; OXYGEN; TIME FACTORS;

EID: 0037335585     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/0033-7587(2003)159[0328:TOAAAI]2.0.CO;2     Document Type: Article

References (44)

1. L. Chin, G. Merlino and R. A. DePinho, Malignant melanoma: Modern black plague and genetic black box. Genes Dev. 12, 3467-3481 (1998).
2. K. Satyamoorthy, T. Bogenrieder and M. Herlyn, No longer a molecular black box - new clues to apoptosis and drug resistance in melanoma. Trends Mol. Med. 7, 191-194 (2001).
3. M. S. Soengas, P. Capodieci, D. Polsky, J. Mora, M. Esteller, X. Opitz-Araya, R. McCombie, J. G. Herman, W. L. Gerald and S. W. Lowe, Inactivation of the apoptosis effector Apaf-1 in malignant melanoma. Nature 409, 207-211 (2001).
4. D. S. Rigel, R. J. Friedman and A. W. Kopf, The incidence of malignant melanoma in the United States: Issues as we approach the 21st century. J. Am. Acad. Dermatol. 34, 839-847 (1996).
5. D. Reintgen, C. W. Cruse and M. Atkins, Cutaneous malignant melanoma. Clin. Dermatol. 19, 253-261 (2001).
6. K. K. Ang, L. J. Peters, R. S. Weber, W. H. Morrison, R. A. Frankenthaler, A. S. Garden, H. Goepfert, C. S. Ha and R. M. Byers, Postoperative radiotherapy for cutaneous melanoma of the head and neck region. Int. J. Radiat. Oncol. Biol. Phys. 30, 795-798 (1994).
7. F. B. Geara and K. K. Ang, Radiation therapy for malignant melanoma. Surg. Clin. North Am. 76, 1383-1398 (1996).
8. M. Huncharek, J. F. Caubet and R. McGarry, Single-agent DTIC versus combination chemotherapy with or without immunotherapy in metastatic melanoma: A meta-analysis of 3273 patients from 20 randomized trials. Melanoma Res. 11, 75-81 (2001).
9. J. M. Brown and A. J. Giaccia, The unique physiology of solid tumors: Opportunities (and problems) for cancer therapy. Cancer Res. 58, 1408-1416 (1998).
10. T. S. Herman, B. A. Teicher and C. N. Coleman, Interaction of SR-4233 with hyperthermia and radiation in the FSaIIC murine fibrosarcoma tumor system in vitro and in vivo. Cancer Res. 50, 5055-5059 (1990).
11. P. Okunieff, J. de Bie, E. P. Dunphy, D. J. Terris and M. Hockel, Oxygen distributions partly explain the radiation response of human squamous cell carcinomas. Br. J. Cancer 27 (Suppl.), S185-S190 (1996).
12. A. P. van den Berg, A. E. van den Berg-Blok, H. B. Kal and H. S. Reinhold, A moderate elevation of blood glucose level increases the effectiveness of thermoradiotherapy in a rat tumor model II. Improved tumor control at clinically achievable temperatures. Int. J. Radiat. Oncol. Biol. Phys. 50, 793-801 (2001).
13. A. P. van den Berg, A. E. van den Berg-Blok, H. B. Kal and H. S. Reinhold, A moderate elevation of blood glucose level increases the effectiveness of thermoradiotherapy in a rat tumor model. I. Relative contributions of glucose and heating to tumor acidification. Int. J. Radiat. Oncol. Biol. Phys. 50, 783-792 (2001).
14. J. B. Owen, L. R. Coia and G. E. Hanks, Recent patterns of growth in radiation therapy facilities in the United States: A patterns of care study report. Int. J. Radiat. Oncol. Biol. Phys. 24, 983-986 (1992).
15. A. W. Fyles, M. Milosevic, R. Wong, M. C. Kavanagh, M. Pintilie, A. Sun, W. Chapman, W. Levin, L. Manchul and R. P. Hill, Oxygenation predicts radiation response and survival in patients with cervix cancer. Radiother. Oncol. 48, 149-156 (1998).
16. A. Gatenby, H. B. Kessler, J. S. Rosenblum, L. R. Coia, P. J. Moldofsky, W. H. Hartz and G. J. Broder, Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 14, 831-838 (1988).
17. D. M. Brizel, S. P. Scully, J. M. Harrelson, L. J. Layfield, J. M. Bean, L. R. Prosnitz and M. W. Dewhirst, Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res. 56, 941-943 (1996).
18. K. Sundfor, H. Lyng and E. K. Rofstad, Tumour hypoxia and vascular density as predictors of metastasis in squamous cell carcinoma of the uterine cervix. Br. J. Cancer 78, 822-827 (1998).
19. B. G. Wouters, S. A. Weppler, M. Koritzinsky, W. Landuyt, S. Nuyts, J. Theys, R. K. Chiu and P. Lambin, Hypoxia as a target for combined modality treatments. Eur. J. Cancer 38, 240-257 (2002).
20. V. M. Laurence, R. Ward, I. F. Dennis and N. M. Bleehen, Carbogen breathing with nicotinamide improves the oxygen status of tumours in patients. Br. J. Cancer 72, 198-205 (1995).
21. C. M. Glaser, W. Millesi, G. V. Kornek, S. Lang, B. Schull, F. Watzinger, E. Selzer and R. S. Lavey, Impact of hemoglobin level and use of recombinant erythropoietin on efficacy of preoperative chemoradiation therapy for squamous cell carcinoma of the oral cavity and oropharynx. Int. J. Radiat. Oncol. Biol. Phys. 50; 705-715 (2001).
22. J. E. Biaglow, Y. Manevich, D. Leeper, B. Chance, M. W. Dewhirst, W. T. Jenkins, S. W. Tuttle, K. Wroblewski, J. D. Glickson and S. M. Evans, MIBG inhibits respiration: Potential for radio- and hyperthermic sensitization. Int. J. Radiat. Oncol. Biol. Phys. 42, 871-876 (1998).
23. 125]iodobenzylguanidine in the human neuroblastoma cell line SK-N-SH. Cancer Res. 45, 6366-6370 (1985).
24. S. Meller, Targeted radiotherapy for neuroblastoma. Arch. Dis. Child 77, 389-391 (1997).
25. R. Burd, P. R. Wachsberger, J. E. Biaglow, M. L. Wahl, I. Lee and D. B. Leeper, Absence of Crabtree effect in human melanoma cells adapted to growth at low pH: Reversal by respiratory inhibitors. Cancer Res. 61, 5630-5635 (2001).
26. M. Rutgers, G. A. Tytgat, M. Verwijs-Janssen, C. Buitenhuis, P. A. Voute and L. A. Smets, Uptake of the neuron-blocking agent metaiodobenzylguanidine and serotonin by human platelets and neuroadrenergic tumour cells. Int. J. Cancer 54, 290-295 (1993).
27. P. Reuland, L. Geiger, M. H. Thelen, R. Handgretinger, B. Haase, W. Muller-Schauenburg, D. Niethammer and R. Bares, Follow-up in neuroblastoma: Comparison of metaiodobenzylguanidine and a chimeric anti-GD2 antibody for detection of tumor relapse and therapy response. J. Pediatr. Hematol. Oncol. 23, 437-442 (2001).
28. C. Loesberg, H. Van Rooij, W. J. Nooijen, A. J. Meijer and L. A. Smets, Impaired mitochondrial respiration and stimulated glycolysis by m-iodobenzylguanidine (MIBG). Int. J. Cancer 46, 276-281 (1990).
29. 31P magnetic resonance spectroscopy study. Cancer Res. 60, 3532-3536 (2000).
30. A. Kuin, L. Smets, T. Volk, A. Paans, G. Adams, A. Atema, E. Jahde, A. Maas, M. F. Rajewsky and G. Visser, Reduction of intratumoral pH by the mitochondrial inhibitor m-iodobenzylguanidine and moderate hyperglycemia. Cancer Res. 54, 3785-3792 (1994).
31. E. Jahde, T. Volk, A. Atema, L. A. Smets, K. H. Glusenkamp and M. F. Rajewsky, pH in human tumor xenografts and transplanted rat tumors: Effect of insulin, inorganic phosphate and m-iodobenzylguanidine. Cancer Res. 52, 6209-6215 (1992).
32. R. D. Braun, J. L. Lanzen, J. A. Turnage, G. Rosner and M. W. Dewhirst, Effects of the interaction between carbogen and nicotinamide on R3230 Ac tumor blood flow in Fischer 344 rats. Radiat. Res. 155, 724-733 (2001).
33. H. G. Crabtree, Observations of the carbohydrate metabolism of tumours. Biochem. J. 23, 536-545 (1929).
34. O. D. Laerum and O. H. Iversen, pH-Dependence of epidermal respiration under normal conditions and in chemically induced hyperplasia: Comparison with the motochondrial tetrazolium reduction. Arch. Derm. Forsch. 246, 92-102 (1973).
35. S. A. Snyder, J. L. Lanzen, R. D. Braun, G. Rosner, T. W. Secomb, J. Biaglow, D. M. Brizel and M. W. Dewhirst, Simultaneous administration of glucose and hyperoxic gas achieves greater improvement in tumor oxygenation than hyperoxic gas alone. Int. J. Radiat. Oncol. Biol. Phys. 51, 494-506 (2001).
36. L. Nadal-Desbarats, H. Poptani, P. Oprysko, W. T. Jenkins, T. M. Busch, D. S. Nelson, J. D. Glickson, C. J. Koch and S. M. Evans, Effects of hyperglycemia on oxygenation, radiosensitivity and bioenergetic status of subcutaneous RIF-1 tumors. Int. J. Oncol. 21, 103-110 (2002).
37. P. Vaupel, P. Okunieff and M. Kluge, Response of tumour red blood cell flux to hyperthermia and/or hyperglycaemia. Int. J. Hyperthermia 5, 199-210 (1989).
38. P. W. Vaupel and P. G. Okunieff, Role of hypovolemic hemoconcentration in dose-dependent flow decline observed in murine tumors after intraperitoneal administration of glucose or mannitol. Cancer Res. 48, 7102-7106 (1988).
39. B. G. Wouters and J. M. Brown, Cells at intermediate oxygen levels can be more important than the "hypoxic fraction" in determining tumor response to fractionated radiotherapy. Radiat. Res. 147, 541-550 (1997).
40. B. F. Jordan, V. Gregoire, R. J. Demeure, P. Sonveaux, O. Feron, J. O'Hara, V. P. Vanhulle, N. Delzenne and B. Gallez, Insulin increases the sensitivity of tumors to irradiation: Involvement of an increase in tumor oxygenation mediated by a nitric oxide-dependent decrease of the tumor cells oxygen consumption. Cancer Res. 62, 3555-3561 (2002).
41. R. D. Braun, J. L. Lanzen, S. A. Snyder and M. W. Dewhirst, Comparison of tumor and normal tissue oxygen tension measurements using OxyLite or microelectrodes in rodents. Am. J. Physiol. Heart Circ. Physiol. 280, H2533-H2544 (2001).
42. A. Kuin, M. Aalders, M. Lamfers, D. J. van Zuidam, M. Essers, J. H. Beijnen and L. A. Smets, Potentiation of anti-cancer drug activity at low intratumoral pH induced by the mitochondrial inhibitor m-iodobenzylguanidine (MIBG) and its analogue benzylguanidine (BG). Br. J. Cancer 79, 793-801 (1999).
43. I. Lee, J. D. Glickson, M. W. Dewhirst, D. B. Leeper, R. Burd, H. Poptani, L. Nada, W. G. McKenna and J. E. Biaglow, Effect of glucose +/- MIBG on the radiation response of R3230 AC tumors. In Oxygen Transport to Tissue xxii (J. F. Dunn and H. M. Swartz, Eds.), Pabst Science Publishers, Lengerich, Germany, in press.
44. R. A. Coss, J. A. Messinger, M. L. Wahl, P. R. Wachsberger, D. B. Leeper and C. S. Owen, Bicarbonate-dependent proton extrusion in Chinese hamster ovary (CHO) cells adapted to growth at pH 6. 7. Int. J. Hyperthermia 13, 325-336 (1997).